BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34647138)

  • 1. The changing face of Irish head and neck cancer epidemiology: 20 years of data.
    Sexton GP; Walsh P; Moriarty F; O'Neill JP
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3079-3088. PubMed ID: 34647138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
    Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
    Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011.
    Braakhuis BJ; Leemans CR; Visser O
    Oral Oncol; 2014 Jul; 50(7):670-5. PubMed ID: 24735546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007.
    Hwang E; Johnson-Obaseki S; McDonald JT; Connell C; Corsten M
    Oral Oncol; 2013 Nov; 49(11):1072-6. PubMed ID: 24018186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
    BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control.
    de Souza DL; Pérez MM; Curado MP
    Cancer Epidemiol; 2011 Dec; 35(6):510-4. PubMed ID: 21470934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration.
    Di Credico G; Polesel J; Dal Maso L; Pauli F; Torelli N; Luce D; Radoï L; Matsuo K; Serraino D; Brennan P; Holcatova I; Ahrens W; Lagiou P; Canova C; Richiardi L; Healy CM; Kjaerheim K; Conway DI; Macfarlane GJ; Thomson P; Agudo A; Znaor A; Franceschi S; Herrero R; Toporcov TN; Moyses RA; Muscat J; Negri E; Vilensky M; Fernandez L; Curado MP; Menezes A; Daudt AW; Koifman R; Wunsch-Filho V; Olshan AF; Zevallos JP; Sturgis EM; Li G; Levi F; Zhang ZF; Morgenstern H; Smith E; Lazarus P; La Vecchia C; Garavello W; Chen C; Schwartz SM; Zheng T; Vaughan TL; Kelsey K; McClean M; Benhamou S; Hayes RB; Purdue MP; Gillison M; Schantz S; Yu GP; Chuang SC; Boffetta P; Hashibe M; Yuan-Chin AL; Edefonti V
    Br J Cancer; 2020 Oct; 123(9):1456-1463. PubMed ID: 32830199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age Alone Is Not a Barrier to Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer.
    Sexton GP; Walsh P; Moriarty F; O'Neill JP
    Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):275-283. PubMed ID: 35450431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and risk of subtypes of head-neck cancer: the Netherlands Cohort Study.
    Maasland DH; van den Brandt PA; Kremer B; Schouten LJ
    Sci Rep; 2015 Dec; 5():17744. PubMed ID: 26634678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological trends of head and neck Cancer survivors in Alberta: towards improved understanding of the burden of disease.
    Song JS; Vallance P; Biron V; Jeffery CC
    J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):46. PubMed ID: 32631452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.
    Tsuge H; Kawakita D; Taniyama Y; Oze I; Koyanagi YN; Hori M; Nakata K; Sugiyama H; Miyashiro I; Oki I; Nishino Y; Katanoda K; Ito Y; Shibata A; Matsuda T; Iwasaki S; Matsuo K; Ito H
    Cancer Sci; 2024 Feb; 115(2):623-634. PubMed ID: 37994633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
    Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
    Chidambaram S; Hong SA; Simpson MC; Osazuwa-Peters N; Ward GM; Massa ST
    Oral Oncol; 2022 Nov; 134():106132. PubMed ID: 36191478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid reflux and head and neck cancer risk: A nationwide registry over 13 years.
    Kuo CL; Chen YT; Shiao AS; Lien CF; Wang SJ
    Auris Nasus Larynx; 2015 Oct; 42(5):401-5. PubMed ID: 25998850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Hepatitis C Virus and Head and Neck Cancers.
    Mahale P; Sturgis EM; Tweardy DJ; Ariza-Heredia EJ; Torres HA
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
    Dansky Ullmann C; Harlan LC; Shavers VL; Stevens JL
    Cancer; 2012 Sep; 118(18):4452-61. PubMed ID: 22252676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.
    LeHew CW; Weatherspoon DJ; Peterson CE; Goben A; Reitmajer K; Sroussi H; Kaste LM
    Epidemiol Rev; 2017 Jan; 39(1):132-147. PubMed ID: 28402398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
    Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
    Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.